ATTD: Advanced Technologies and Treatments for Diabetes

In this episode of ATTD 2026 Conference Catch-Up, we dive into Transforming Diabetes Management with Artificial Intelligence (AI), featuring cutting-edge research on how AI-driven technologies are reshaping personalized diabetes care and automated insulin delivery. 
Join us as we summarize key takeaways from these thought-provoking presentations: 
• Combining Digital Twins and LLMs for Advanced Personalized Insulin Therapy in Type 1 Diabetes – Dr. Giacomo Cappon 
• A Week of Automated Insulin Delivery Used to Titrate Basal Insulin in Type 2 Diabetes – Dr. Heman Shakeri 
• Fully Automated Closed-Loop Based on Artificial Intelligence – Prof. Marc D. Breton 
This episode is an essential listen for clinicians, endocrinologists, diabetes researchers, and digital health professionals looking to understand the evolving role of artificial intelligence in optimizing insulin therapy and automated diabetes care. 
Enjoy the listen! 
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. 
ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona. https://attd.kenes.com

In this episode of ATTD 2026 Conference Catch-Up, we dive into Hot from the Oven, featuring the latest advancements in diabetes care and treatments. Join us as we summarize key takeaways from these thought-provoking presentations: 
• Evaluation of CGM-based Insulin Dose Guidance System in People with Type 1 and Type 2 Diabetes: Single Arm Feasibility Study - Prof. Andrej Janež 
• FREEDM2 RCT: New Insights into CGM with Basal Insulin in T2DM - Dr. Emma G. Wilmot 
• Efficacy and Safety of Tirzepatide Compared with Intensified Conventional Care in Adults Initiating Treatment Early in the Course of Type 2 Diabetes: Results from SURPASS-Early Study after 2 Years of Treatment - Prof. Stefano Del Prato 
• The Progress Study: Phase 1/2 Clinical Trial of KRIYA-839, a Novel AAV Gene Therapy for Adults with Type 1 Diabetes - Dr. Jeremy Pettus 
This episode is an essential listen for healthcare professionals in endocrinology and diabetes care, looking to stay up-to-date with cutting-edge research and treatment advancements. 
Enjoy the listen! 
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. 
ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. attd.kenes.com

We’re excited to launch the ATTD 2026 Conference Catch-Up, a brand-new, AI-powered podcast designed for healthcare professionals who want to stay ahead in diabetes care. 
Whether you’re attending ATTD 2026 in Barcelona or following from afar, this podcast ensures you don’t miss a thing. Using AI-driven podcast generation, we’ll bring you key takeaways from select sessions, breaking down the latest in screening and treatment of T1D, CGM, new technologies, AI use, weight management in diabetes, and more. 
Get ready for insightful summaries! 
ATTD 2026 is taking place on 11-14 March, in Barcelona, Spain. It's the ultimate conference to discover the latest worldwide research, devices, therapies and developments in the diabetes field. 
Find out more: https://attd.kenes.com/

In this episode of ATTD Tech Connect, host Julie Taplin and Dr Anna Korsgaard Berg discuss skin care management for people living with diabetes using diabetes technology.
They discuss:
The different skin layers and how they can be impacted by the use of diabetes technology

How poor skin integrity directly affects glucose outcomes

Things to look out for and ask as a clinician

Some practical prevention strategies

Latest research on using ultrasounds to measure skin depth

Dr Anna Korsgaard Berg is a Diabetes researcher at Steno Diabetes Center, Copenhagen and works in Pediatrics at Herlev Hospital.
This series is sponsored by Medtronic Diabetes.
Explore further resources:
ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.

WePartner Online and Medtronic Diabetes Academy

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode of ATTD Tech Connect, host Julie Taplin and Professor Katarzyna Cyranka, clinical psychologist and psychotherapist, discuss the important topic of burden and quality of life related to diabetes and diabetes technologies for people living with diabetes.
They discuss:
Distinguishing diabetes distress from diabetes burnout

Possible sources of diabetes distress

The role of diabetes technology, especially AHCL, in reducing diabetes distress

Signs to watch out for as clinicians, nurses, and educators

Tools to assist in naming and identifying sources of diabetes distress

Professor Katarzyna Cyranka is a clinical psychologist and certified psychotherapist, based in Krakow, Poland. 
This series is sponsored by Medtronic Diabetes.
Explore further resources:
ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.

WePartner Online and Medtronic Diabetes Academy

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.